Can one stop nucleic acid sampling (OSNA) predict nodal positivity following neoadjuvant chemotherapy? A prospective cohort study of 293 patients.

Until recently, axillary node clearance had long been the standard of care in patients with axillary node‐positive disease. One stop nucleic acid sampling (OSNA) has been used to guide intraoperative decision‐making regarding suitability for axillary node clearance (ANC). The aim of this study is to...

Descripción completa

Detalles Bibliográficos
Publicado en:Breast Journal Vol. 27; no. 7; pp. 581 - 586
Autores principales: Batt, Jeremy, Schrire, Timothy, Rayter, Zenon
Formato: research tables/charts Journal Article
Publicado: Wiley-Blackwell Jul2021
Acceso en línea:Ver este registro en EBSCOhost